mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.6 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.6 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.031 |
0.6 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |